| 15372456 |
2004 |
AIB1 at 20q gain |
NA |
NCOA3 |
Details |
| 15372456 |
2004 |
CASPASE8 deletion |
NA |
CASP8 |
Details |
| 15372456 |
2004 |
CCND1 gain |
NA |
CCND1 |
Details |
| 15372456 |
2004 |
c-MYC gain |
NA |
MYC |
Details |
| 15372456 |
2004 |
DMD gain |
NA |
DMD |
Details |
| 15372456 |
2004 |
EGFR gain |
NA |
EGFR |
Details |
| 15372456 |
2004 |
EMS1 gain |
NA |
CTTN |
Details |
| 15372456 |
2004 |
FGF4/FGF3 gain |
NA |
NA |
Details |
| 15372456 |
2004 |
MTAP deletion |
NA |
MTAP |
Details |
| 15372456 |
2004 |
SERPINE1 gain |
NA |
SERPINE1 |
Details |
| 15372456 |
2004 |
TP63 gain |
NA |
TP63 |
Details |
| 16285600 |
2005 |
2q14-21 heterozygosity |
NA |
NA |
Details |
| 16285600 |
2005 |
2q36 heterozygosity |
NA |
NA |
Details |
| 16387424 |
2006 |
HO-1 long (GT)(n) repeat |
NA |
HMOX1 |
Details |
| 16387424 |
2006 |
NFKB1-94ins/delATTG |
NA |
NFKB1 |
Details |
| 16470878 |
2006 |
11q gain |
NA |
NA |
Details |
| 16470878 |
2006 |
20q gain |
NA |
NA |
Details |
| 16470878 |
2006 |
3p deletion |
NA |
NA |
Details |
| 16470878 |
2006 |
3q gain |
NA |
NA |
Details |
| 16470878 |
2006 |
5q gain |
NA |
NA |
Details |
| 16470878 |
2006 |
7p gain |
NA |
NA |
Details |
| 16470878 |
2006 |
8q gain |
NA |
NA |
Details |
| 16470878 |
2006 |
9p21 deletion |
NA |
NA |
Details |
| 18617334 |
2008 |
Loss of heterozygosity of the APC gene |
NA |
APC |
Details |
| 20537188 |
2010 |
10p12 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
11q13 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
11q23-25 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
12q22 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
12q24 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
14q23-32 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
16q22 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
18q11.2 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
1p21 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
20q amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
21q deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
22q deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
3q21-29 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
5p15 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
5q11-12 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
5q14-15 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
5q31 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
7p12 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
8p21-22 deletion |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
8q21-24 amplification |
Metastasis and Survival |
NA |
Details |
| 20537188 |
2010 |
9p21 deletion |
Metastasis and Survival |
NA |
Details |
| 20579853 |
2010 |
c-erbB2 amplification |
NA |
ERBB2 |
Details |
| 20579853 |
2010 |
c-MYC amplification |
NA |
MYC |
Details |
| 21334929 |
2011 |
ABCA5 deletion |
NA |
ABCA5 |
Details |
| 21334929 |
2011 |
CHRDL1 deletion |
NA |
CHRDL1 |
Details |
| 21334929 |
2011 |
CKAP2L deletion |
NA |
CKAP2L |
Details |
| 21334929 |
2011 |
CKAP2L gain |
NA |
CKAP2L |
Details |
| 21334929 |
2011 |
CTTNBP2NL deletion |
NA |
CTTNBP2NL |
Details |
| 21334929 |
2011 |
DDEF1 deletion |
NA |
ASAP1 |
Details |
| 21334929 |
2011 |
EDNRB deletion |
NA |
EDNRB |
Details |
| 21334929 |
2011 |
EIF4E3 deletion |
NA |
EIF4E3 |
Details |
| 21334929 |
2011 |
FAM5B amplification |
NA |
BRINP2 |
Details |
| 21334929 |
2011 |
FBXO3 deletion |
NA |
FBXO3 |
Details |
| 21334929 |
2011 |
FGF10 deletion |
NA |
FGF10 |
Details |
| 21334929 |
2011 |
GATAD2B deletion |
NA |
GATAD2B |
Details |
| 21334929 |
2011 |
GRM3 deletion |
NA |
GRM3 |
Details |
| 21334929 |
2011 |
HDAC9 deletion |
NA |
HDAC9 |
Details |
| 21334929 |
2011 |
HTR2C deletion |
NA |
HTR2C |
Details |
| 21334929 |
2011 |
NEUROD4 deletion |
NA |
NEUROD4 |
Details |
| 21334929 |
2011 |
NLGN1 gain |
NA |
NLGN1 |
Details |
| 21334929 |
2011 |
PDLIM5 deletion |
NA |
PDLIM5 |
Details |
| 21334929 |
2011 |
PIK3CA gain |
NA |
PIK3CA |
Details |
| 21334929 |
2011 |
REL deletion |
NA |
RELA |
Details |
| 21334929 |
2011 |
RHOA deletion |
NA |
RHOA |
Details |
| 21334929 |
2011 |
RNF36 gain |
NA |
TRIM69 |
Details |
| 21334929 |
2011 |
TCF8 deletion |
NA |
ZEB1 |
Details |
| 21334929 |
2011 |
THRAP3 deletion |
NA |
THRAP3 |
Details |
| 21334929 |
2011 |
TIPARP gain |
NA |
TIPARP |
Details |
| 21617881 |
2011 |
11p15 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
11q13 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
11q13 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
11q22 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
16p13.3 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
20q13.3 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
20q13.3 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
22q11 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
2p25.1 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
3p14 loss |
NA |
NA |
Details |
| 21617881 |
2011 |
3p22 loss |
NA |
NA |
Details |
| 21617881 |
2011 |
4q35.2 loss |
NA |
NA |
Details |
| 21617881 |
2011 |
5p15 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
5p15.33 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
7p11 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
7p22 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
7p22.3 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
8q21.1-24.3 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
8q24 gain |
NA |
NA |
Details |
| 21617881 |
2011 |
9q34.3 gain |
NA |
NA |
Details |
| 21853135 |
2011 |
11q11 amplification |
NA |
NA |
Details |
| 21853135 |
2011 |
12p13.31 amplification |
NA |
NA |
Details |
| 21853135 |
2011 |
17q21.2 deletion |
NA |
NA |
Details |
| 21853135 |
2011 |
20p13 amplification |
NA |
NA |
Details |
| 21853135 |
2011 |
6q16.3 deletion |
NA |
NA |
Details |
| 21853135 |
2011 |
7q34 deletion |
NA |
NA |
Details |
| 21853135 |
2011 |
8q22.2~24.3 amplifications |
Recurrence and Survival |
NA |
Details |
| 22470160 |
2012 |
miR-10a CNV |
NA |
MIR10A |
Details |
| 22470160 |
2012 |
miR-140-3p CNV |
Metastasis |
MIR140 |
Details |
| 22470160 |
2012 |
miR-149 CNV |
NA |
MIR149 |
Details |
| 22470160 |
2012 |
miR-192 CNV |
NA |
MIR192 |
Details |
| 22470160 |
2012 |
miR-29a CNV |
Metastasis |
MIR29A |
Details |
| 22470160 |
2012 |
miR-29c CNV |
Metastasis |
MIR29C |
Details |
| 22470160 |
2012 |
miR-34c-5p CNV |
NA |
MIR34C |
Details |
| 23258604 |
2013 |
Deletion at chromosome 3q26.1 |
NA |
NA |
Details |
| 23619168 |
2013 |
Gain of 3q |
NA |
NA |
Details |
| 23619168 |
2013 |
Gain of 8q |
NA |
MYC |
Details |
| 23619168 |
2013 |
Gain of 9q |
NA |
NFIB |
Details |
| 23619168 |
2013 |
Loss of 18p |
NA |
NA |
Details |
| 23619168 |
2013 |
Loss of 3p |
NA |
FHIT |
Details |
| 23619168 |
2013 |
Loss of 8p |
Survival |
CSMD1 |
Details |
| 23619168 |
2013 |
Loss of 9p |
NA |
NFIB |
Details |
| 24292195 |
2013 |
CCND1 amplification |
NA |
CCND1 |
Details |
| 24292195 |
2013 |
DDX3X recurrent homozygous deletion |
NA |
DDX3X |
Details |
| 24292195 |
2013 |
DROSHA amplification |
NA |
DROSHA |
Details |
| 24292195 |
2013 |
Heterozygous deletions of CDH19 |
NA |
CDH19 |
Details |
| 24292195 |
2013 |
Heterozygous deletions of CDKN2A |
NA |
CDKN2A |
Details |
| 24292195 |
2013 |
Homozygous deletion of GSTT1 |
NA |
GSTT1 |
Details |
| 24292195 |
2013 |
MECOM amplification |
NA |
MECOM |
Details |
| 24292195 |
2013 |
MMP gene cluster region on chromosome 11q amplification |
NA |
NA |
Details |
| 24292195 |
2013 |
TP63 amplification |
NA |
TP63 |
Details |
| 25846277 |
2015 |
1q21.3 mutation |
NA |
NA |
Details |
| 25881131 |
2015 |
Chromosome 17 trisomy |
Carcinogenesis and Differentiation |
NA |
Details |
| 25881131 |
2015 |
TP53 amplification or duplication |
Carcinogenesis and Differentiation |
TP53 |
Details |
| 26247464 |
2015 |
CDKN2A amplification |
NA |
CDKN2A |
Details |
| 26247464 |
2015 |
CDKN2A deletion |
NA |
CDKN2A |
Details |
| 26247464 |
2015 |
EGFR amplification |
NA |
EGFR |
Details |
| 26247464 |
2015 |
EGFR deletion |
NA |
EGFR |
Details |
| 26247464 |
2015 |
ERBB2 amplification |
NA |
ERBB2 |
Details |
| 26247464 |
2015 |
ERBB2 deletion |
NA |
ERBB2 |
Details |
| 26247464 |
2015 |
FAT1 amplification |
NA |
FAT1 |
Details |
| 26247464 |
2015 |
FAT1 deletion |
NA |
FAT1 |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 3q |
NA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 5p |
NA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 8q |
NA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 3p |
NA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 8p |
NA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 9p |
NA |
NA |
Details |
| 26247464 |
2015 |
SMAD4 amplification |
NA |
SMAD4 |
Details |
| 26247464 |
2015 |
SMAD4 deletion |
NA |
SMAD4 |
Details |
| 26604578 |
2015 |
C-deletion mutation in exon 4 codon 63 of p53 |
NA |
TP53 |
Details |
| 26934577 |
2016 |
11p12 amplification |
NA |
NA |
Details |
| 26934577 |
2016 |
11q13 amplification |
NA |
NA |
Details |
| 26934577 |
2016 |
12q14 amplification |
NA |
NA |
Details |
| 26934577 |
2016 |
12q15 amplification |
NA |
NA |
Details |
| 26934577 |
2016 |
9p12 amplification |
NA |
NA |
Details |
| 26934577 |
2016 |
BAG1 amplification |
NA |
BAG1 |
Details |
| 26934577 |
2016 |
BAG1 deletion |
NA |
BAG1 |
Details |
| 26934577 |
2016 |
CLTA amplification |
NA |
CLTA |
Details |
| 26934577 |
2016 |
FOSL1 amplification |
NA |
FOSL1 |
Details |
| 26934577 |
2016 |
FRS2 amplification |
NA |
FRS2 |
Details |
| 26934577 |
2016 |
GDF5 amplification |
NA |
GDF5 |
Details |
| 26934577 |
2016 |
MDM2 amplification |
NA |
MDM2 |
Details |
| 26934577 |
2016 |
RBPJ amplification |
NA |
RBPJ |
Details |
| 26934577 |
2016 |
RELA amplification |
NA |
RELA |
Details |
| 26934577 |
2016 |
TRAF6 amplification |
NA |
TRAF6 |
Details |
| 27491556 |
2016 |
CDK6 gain |
NA |
CDK6 |
Details |
| 27491556 |
2016 |
CDKN1B gain |
NA |
CDKN1B |
Details |
| 27491556 |
2016 |
GSTP1 gain |
NA |
GSTP1 |
Details |
| 27491556 |
2016 |
KLK3 gain |
NA |
KLK3 |
Details |
| 27491556 |
2016 |
PAH loss |
NA |
PAH |
Details |
| 27491556 |
2016 |
PAX6 loss |
NA |
PAX6 |
Details |
| 27491556 |
2016 |
PMP22 loss |
NA |
PMP22 |
Details |
| 27491556 |
2016 |
STK11 gain |
NA |
STK11 |
Details |
| 27721596 |
2016 |
GSTT1 null |
NA |
GSTT1 |
Details |
| 27381359 |
2017 |
IVS4-30 del T deletion mutation |
NA |
PTEN |
Details |
| 27889930 |
2017 |
AKT1 CNV |
NA |
AKT1 |
Details |
| 27889930 |
2017 |
BRAF CNV |
NA |
BRAF |
Details |
| 27889930 |
2017 |
CDKN2A CNV |
NA |
CDKN2A |
Details |
| 27889930 |
2017 |
EGFR CNV |
Metastasis |
EGFR |
Details |
| 27889930 |
2017 |
ERBB2 CNV |
Metastasis |
ERBB2 |
Details |
| 27889930 |
2017 |
ERBB4 CNV |
Metastasis |
ERBB4 |
Details |
| 27889930 |
2017 |
FGFR1 CNV |
Metastasis |
FGFR1 |
Details |
| 27889930 |
2017 |
FGFR3 CNV |
Metastasis |
FGFR3 |
Details |
| 27889930 |
2017 |
FLT3 CNV |
Metastasis |
FLT3 |
Details |
| 27889930 |
2017 |
HRAS CNV |
NA |
HRAS |
Details |
| 27889930 |
2017 |
KIT CNV |
Metastasis |
KIT |
Details |
| 27889930 |
2017 |
MET CNV |
Metastasis |
MET |
Details |
| 27889930 |
2017 |
NOTCH1 CNV |
NA |
NOTCH1 |
Details |
| 27889930 |
2017 |
PFGFRA CNV |
Metastasis |
PDGFRA |
Details |
| 27889930 |
2017 |
PIK3CA CNV |
NA |
PIK3CA |
Details |
| 27889930 |
2017 |
SMAD4 CNV |
NA |
SMAD4 |
Details |
| 28289590 |
2017 |
GSTM1 [-] |
NA |
GSTM1 |
Details |
| 28289590 |
2017 |
GSTT1 [-] |
NA |
GSTT1 |
Details |
| 28384287 |
2017 |
10p13-p12.2 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
11q13.1-q13.2 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
11q13.3 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
11q13.3-q13.4 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
11q13.4 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
3p21.31 deletion |
NA |
NA |
Details |
| 28384287 |
2017 |
3p26.3-p26.1 deletion |
NA |
NA |
Details |
| 28384287 |
2017 |
3q13.32-q21.2 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
3q21.2-q26.1 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
3q25.31-q26.1 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
3q26.1-q26.31 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
3q27.3-q28 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
5p13.1 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
5p13.2-p13.1 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
5p13.3-p13.2 amplification |
NA |
NA |
Details |
| 28384287 |
2017 |
7p11.2 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
7p22.1-p11.2 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
7p22.3-p22.1 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8p23.2 deletion |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q11.21-q12.1 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q12.1 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q21.13-q21.2 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q21.2-q21.3 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q22.3-q23.1 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q23.1-q24.11 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q24.12-q24.13 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q24.13 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
8q24.3 amplification |
Staging |
NA |
Details |
| 28384287 |
2017 |
9p21.1-p13.3 amplification |
Metastasis |
NA |
Details |
| 28435450 |
2017 |
ANO1 CNV |
Tumorigenesis |
ANO1 |
Details |
| 28435450 |
2017 |
CCND1 CNV |
Tumorigenesis |
CCND1 |
Details |
| 28435450 |
2017 |
CDKN2A CNV |
Tumorigenesis |
CDKN2A |
Details |
| 28435450 |
2017 |
CSMD1 CNV |
Tumorigenesis |
CSMD1 |
Details |
| 28435450 |
2017 |
FGF3 CNV |
Tumorigenesis |
FGF3 |
Details |
| 28435450 |
2017 |
FGF4 CNV |
Tumorigenesis |
FGF4 |
Details |
| 28938622 |
2017 |
CCND1 CNV |
NA |
CCND1 |
Details |
| 28938622 |
2017 |
CCND2 CNV |
NA |
CCND2 |
Details |
| 28938622 |
2017 |
HRAS CNV |
NA |
HRAS |
Details |
| 28938622 |
2017 |
KRAS CNV |
NA |
KRAS |
Details |
| 28938622 |
2017 |
NRAS CNV |
NA |
NRAS |
Details |
| 29896272 |
2018 |
BRCA1 CNV |
Metastasis and Recurrence |
BRCA1 |
Details |
| 29896272 |
2018 |
CADM1 CNV |
Survival |
CADM1 |
Details |
| 29896272 |
2018 |
CASR CNV |
Survival |
CASR |
Details |
| 29896272 |
2018 |
CDH13 CNV |
Survival |
CDH13 |
Details |
| 29896272 |
2018 |
CDKN2A CNV |
Metastasis and Recurrence |
CDKN2A |
Details |
| 29896272 |
2018 |
CHFR CNV |
Metastasis and Recurrence |
CHFR |
Details |
| 29896272 |
2018 |
GATA5 CNV |
Metastasis and Recurrence |
GATA5 |
Details |
| 29896272 |
2018 |
PAX5 CNV |
Survival |
PAX5 |
Details |
| 29896272 |
2018 |
PYCARD CNV |
Metastasis and Recurrence |
PYCARD |
Details |
| 29896272 |
2018 |
RARB CNV |
Survival |
RARB |
Details |
| 29896272 |
2018 |
RB1 CNV |
Survival |
RB1 |
Details |
| 29896272 |
2018 |
STK11 CNV |
Metastasis and Recurrence |
STK11 |
Details |
| 29896272 |
2018 |
TP53 CNV |
Metastasis and Recurrence |
TP53 |
Details |
| 29896272 |
2018 |
TP73 CNV |
Survival |
TP73 |
Details |
| 29896272 |
2018 |
VHL CNV |
Metastasis and Recurrence |
VHL |
Details |
| 31949709 |
2018 |
Homozygous deletion of RB1CC1 |
Metastasis |
RB1CC1 |
Details |
| 31949709 |
2018 |
Homozygous deletion of TP53 |
Metastasis |
TP53 |
Details |
| 30964915 |
2019 |
DMRT1 CNV |
NA |
DMRT1 |
Details |
| 30964915 |
2019 |
DMRT3 CNV |
NA |
DMRT3 |
Details |
| 30964915 |
2019 |
ERMP1 CNV |
NA |
ERMP1 |
Details |
| 30964915 |
2019 |
FOXD4 CNV |
NA |
FOXD4 |
Details |
| 30964915 |
2019 |
IL33 CNV |
NA |
IL33 |
Details |
| 30964915 |
2019 |
JAK2 CNV |
NA |
JAK2 |
Details |
| 30964915 |
2019 |
KANK1 CNV |
NA |
KANK1 |
Details |
| 30964915 |
2019 |
SLC1A1 CNV |
NA |
SLC1A1 |
Details |
| 30964915 |
2019 |
SMARCA2 CNV |
NA |
SMARCA2 |
Details |
| 30964915 |
2019 |
UHRF2 CNV |
NA |
UHRF2 |
Details |
| 31244319 |
2019 |
GSTM1 deletional variants |
NA |
GSTM1 |
Details |
| 31244319 |
2019 |
GSTT1 deletional variants |
NA |
GSTT1 |
Details |
| 32115621 |
2020 |
CELSR3 amplification |
Adhesion |
CELSR3 |
Details |
| 32115621 |
2020 |
COL1A1 amplification |
Adhesion |
COL1A1 |
Details |
| 32115621 |
2020 |
COL6A4 (COL6A4P1) amplification |
Adhesion |
COL6A4P1 |
Details |
| 32115621 |
2020 |
DDR1 amplification |
Adhesion |
DDR1 |
Details |
| 32115621 |
2020 |
Egfr amplification |
NA |
EGFR |
Details |
| 32115621 |
2020 |
ITGA3 amplification |
Adhesion |
ITGA3 |
Details |
| 32115621 |
2020 |
ITGA4 amplification |
Adhesion |
ITGB4 |
Details |
| 32115621 |
2020 |
NCOR1 amplification |
NA |
NCOR1 |
Details |
| 32115621 |
2020 |
PCDH11X amplification |
Adhesion |
PCDH11X |
Details |
| 32115621 |
2020 |
PIK3C2A amplification |
NA |
PIK3C2A |
Details |
| 32115621 |
2020 |
PIK3CA amplification |
NA |
PIK3CA |
Details |
| 32115621 |
2020 |
PIK3CB amplification |
NA |
PIK3CB |
Details |
| 32115621 |
2020 |
PIK3IP1 amplification |
NA |
PIK3IP1 |
Details |
| 32115621 |
2020 |
PIK3R1 amplification |
NA |
PIK3R1 |
Details |
| 32115621 |
2020 |
PIK3R3 amplification |
NA |
PIK3R3 |
Details |
| 32115621 |
2020 |
PIK3R4 amplification |
NA |
PIK3R4 |
Details |
| 32115621 |
2020 |
PIK3R5 amplification |
NA |
PIK3R5 |
Details |
| 32115621 |
2020 |
PIK3R6 amplification |
NA |
PIK3R6 |
Details |
| 32115621 |
2020 |
PLEC amplification |
Adhesion |
PLEC |
Details |
| 32194051 |
2020 |
p16INK4A deletion |
NA |
CDKN2A |
Details |
| 32251686 |
2020 |
Deletion of 181,257,187-181,247,386 at 5q35.3 |
Invasion, Migration, and Proliferation |
NA |
Details |
| 32733958 |
2020 |
NANOG CNV |
NA |
NANOG |
Details |
| 33610067 |
2021 |
1p36 deletion |
NA |
NA |
Details |
| 33610067 |
2021 |
1pTEL deletion |
NA |
NA |
Details |
| 33610067 |
2021 |
1q25 deletion |
NA |
NA |
Details |
| 33610067 |
2021 |
Monosomy of chromosome 17 |
NA |
NA |
Details |
| 33610067 |
2021 |
Trisomy/Polysomy of chromosome 17 |
NA |
NA |
Details |
| 34136393 |
2021 |
14q11 amplification |
NA |
NA |
Details |
| 34136393 |
2021 |
1q31 amplification |
NA |
NA |
Details |
| 34136393 |
2021 |
22q11 amplification |
NA |
NA |
Details |
| 34136393 |
2021 |
22q13 amplification |
NA |
NA |
Details |
| 34136393 |
2021 |
7q35 amplification |
NA |
NA |
Details |
| 34126417 |
2021 |
HOXA9 amplification |
NA |
HOXA9 |
Details |
| 34126417 |
2021 |
HOXB13 amplification |
NA |
HOXB13 |
Details |
| 34126417 |
2021 |
IRX4 amplification |
NA |
IRX4 |
Details |
| 34957065 |
2021 |
NSUN3 amplification |
NA |
NSUN3 |
Details |
| 34957065 |
2021 |
NSUN2 amplification |
NA |
NSUN2 |
Details |
| 34957065 |
2021 |
DNMT3B amplification |
NA |
DNMT3B |
Details |
| 34957065 |
2021 |
NOP2 amplification |
NA |
NOP2 |
Details |
| 34957065 |
2021 |
YBX1 amplification |
NA |
YBX1 |
Details |
| 34957065 |
2021 |
ALKBH1 amplification |
NA |
ALKBH1 |
Details |
| 34957065 |
2021 |
NSUN4 amplification |
NA |
NSUN4 |
Details |
| 34957065 |
2021 |
TET3 amplification |
NA |
TET3 |
Details |
| 34957065 |
2021 |
ALYREF deletion |
NA |
ALYREF |
Details |
| 36167721 |
2022 |
Single copy CNV of GSTM1 |
Survival |
GSTM1 |
Details |
| 34638642 |
2022 |
TRMT61A CNV |
Metastasis, Survival, and Tumorigenesis |
TRMT61A |
Details |
| 34638642 |
2022 |
TRMT61B CNV |
Metastasis, Survival, and Tumorigenesis |
TRMT61B |
Details |
| 34638642 |
2022 |
YTHDC1 CNV |
Metastasis, Survival, and Tumorigenesis |
YTHDC1 |
Details |
| 34638642 |
2022 |
ALKBH3 CNV |
Metastasis, Survival, and Tumorigenesis |
ALKBH3 |
Details |
| 34638642 |
2022 |
ALKBH1 CNV |
Metastasis, Survival, and Tumorigenesis |
ALKBH1 |
Details |
| 34638642 |
2022 |
YTHDF1 CNV |
Metastasis, Survival, and Tumorigenesis |
YTHDF1 |
Details |
| 34638642 |
2022 |
TRMT61B CNV |
Metastasis, Survival, and Tumorigenesis |
TRMT61B |
Details |
| 34638642 |
2022 |
YTHDF2 CNV |
Metastasis, Survival, and Tumorigenesis |
YTHDF2 |
Details |
| 35670448 |
2022 |
ANO1 CNV |
NA |
ANO1 |
Details |
| 35670448 |
2022 |
FADD CNV |
NA |
FADD |
Details |
| 35670448 |
2022 |
FGF3 CNV |
NA |
FGF3 |
Details |
| 35670448 |
2022 |
FGF4 CNV |
NA |
FGF4 |
Details |
| 35670448 |
2022 |
CCND1 CNV |
NA |
CCND1 |
Details |
| 35670448 |
2022 |
CTTN CNV |
NA |
CTTN |
Details |
| 35670448 |
2022 |
EGFR CNV |
NA |
EGFR |
Details |
| 35670448 |
2022 |
LANCL2 CNV |
NA |
LANCL2 |
Details |
| 35670448 |
2022 |
ORAOV1 (LTO1) CNV |
NA |
LTO1 |
Details |
| 35670448 |
2022 |
SHANK2 CNV |
NA |
SHANK2 |
Details |
| 35670448 |
2022 |
CDKN2A CNV |
NA |
CDKN2A |
Details |
| 35670448 |
2022 |
CDKN2B CNV |
NA |
CDKN2B |
Details |
| 33665778 |
2022 |
CLDN1 CNV |
Metastasis |
CLDN1 |
Details |
| 37887269 |
2023 |
PRMT5 CNV |
Tumorigenesis |
PRMT5 |
Details |
| 37887269 |
2023 |
APEX1(APE1) CNV |
Tumorigenesis |
APEX1 |
Details |
| 37828627 |
2023 |
DLD CNV |
NA |
DLD |
Details |
| 37828627 |
2023 |
DLST CNV |
NA |
DLST |
Details |
| 37828627 |
2023 |
GCSH CNV |
NA |
GCSH |
Details |
| 37828627 |
2023 |
LIPH1 CNV |
NA |
LIPT1 |
Details |
| 37828627 |
2023 |
SLC31A1 CNV |
NA |
SLC31A1 |
Details |
| 37828627 |
2023 |
ATP7A CNV |
NA |
ATP7A |
Details |
| 37828627 |
2023 |
ATP7B CNV |
NA |
ATP7B |
Details |
| 37828627 |
2023 |
DBT CNV |
NA |
DBT |
Details |
| 37828627 |
2023 |
DLAT CNV |
NA |
DLAT |
Details |
| 37828627 |
2023 |
FDX1 CNV |
NA |
FDX1 |
Details |
| 37828627 |
2023 |
LIAS CNV |
NA |
LIAS |
Details |
| 37828627 |
2023 |
PDHA1 CNV |
NA |
PDHA1 |
Details |
| 37828627 |
2023 |
PDHB CNV |
NA |
PDHB |
Details |